Calcium in the coronary arteries is a known cardiac risk factor. However, new data suggest it may actually tell us more about a person's overall health than researchers previously believed. 

Researchers warned that “aggressive procedural modifications” should not be necessary during TAVR to mitigate the risk of prosthesis-patient mismatch. This appears to be true for patients receiving both self-expanding and balloon-expandable TAVR valves.

Although the drug can slow the progression of cognitive decline, it may have little impact on damage already done by AD prior to treatment.

Sports fans may actually be emotionally dependent on their team’s performance on a neural level, according to functional imaging data. 

Researchers are hopeful their new approach to developing MRI contrast will "pave the way for safer, smarter imaging in clinical diagnostics."

Researchers tracked data from nearly 8,000 patients evaluated with Heartflow's FDA-cleared Plaque Analysis software. Overall, the technology's Plaque Staging feature was found to provide significant value during the diagnosis and management of these patients.

The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine. 

Consistently incorporating unsalted peanuts into a person’s diet enhances cerebral blood flow to multiple brain regions.